Academic Journal
Virtual optimization of guideline‐directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT‐HF pilot study
| العنوان: | Virtual optimization of guideline‐directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT‐HF pilot study |
|---|---|
| المؤلفون: | Bhatt, Ankeet S., Varshney, Anubodh S., Nekoui, Mahan, Moscone, Alea, Cunningham, Jonathan W., Jering, Karola S., Patel, Parth N., Sinnenberg, Lauren E., Bernier, Thomas D., Buckley, Leo F., Cook, Bryan M., Dempsey, Jillian, Kelly, Julie, Knowles, Danielle M., Lupi, Kenneth, Malloy, Rhynn, Matta, Lina S., Rhoten, Megan N., Sharma, Krishan, Snyder, Caroline A., Ting, Clara, McElrath, Erin E., Amato, Mary G., Alobaidly, Maryam, Ulbricht, Catherine E., Choudhry, Niteesh K., Adler, Dale S., Vaduganathan, Muthiah |
| المصدر: | European Journal of Heart Failure ; volume 23, issue 7, page 1191-1201 ; ISSN 1388-9842 1879-0844 |
| بيانات النشر: | Wiley |
| سنة النشر: | 2021 |
| المجموعة: | Wiley Online Library (Open Access Articles via Crossref) |
| الوصف: | Aims Implementation of guideline‐directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) remains incomplete. Non‐cardiovascular hospitalization may present opportunities for GDMT optimization. We assessed the efficacy and durability of a virtual, multidisciplinary ‘GDMT Team’ on medical therapy prescription for HFrEF. Methods and results Consecutive hospitalizations in patients with HFrEF (ejection fraction ≤40%) were prospectively identified from 3 February to 1 March 2020 (usual care group) and 2 March to 28 August 2020 (intervention group). Patients with critical illness, de novo heart failure, and systolic blood pressure <90 mmHg in the preceeding 24 hs prior to enrollment were excluded. In the intervention group, a pharmacist–physician GDMT Team provided optimization suggestions to treating teams based on an evidence‐based algorithm. The primary outcome was a GDMT optimization score, the sum of positive (+1 for new initiations or up‐titrations) and negative therapeutic changes (−1 for discontinuations or down‐titrations) at hospital discharge. Serious in‐hospital safety events were assessed. Among 278 consecutive encounters with HFrEF, 118 met eligibility criteria; 29 (25%) received usual care and 89 (75%) received the GDMT Team intervention. Among usual care encounters, there were no changes in GDMT prescription during hospitalization. In the intervention group, β‐blocker (72% to 88%; P = 0.01), angiotensin receptor–neprilysin inhibitor (6% to 17%; P = 0.03), mineralocorticoid receptor antagonist (16% to 29%; P = 0.05), and triple therapy (9% to 26%; P < 0.01) prescriptions increased during hospitalization. After adjustment for clinically relevant covariates, the GDMT Team was associated with an increase in GDMT optimization score (+0.58; 95% confidence interval +0.09 to +1.07; P = 0.02) . There were no serious in‐hospital adverse events. Conclusions Non‐cardiovascular hospitalizations are a potentially safe and effective setting for GDMT optimization. A ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1002/ejhf.2163 |
| الاتاحة: | http://dx.doi.org/10.1002/ejhf.2163 https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2163 https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ejhf.2163 |
| Rights: | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| رقم الانضمام: | edsbas.65DAE553 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1002/ejhf.2163 |
|---|